References
- Matthes HW, Maldonado R, Simonin F, Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996;383:819–23.
- Sora I, Takahashi N, Funada M, Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci U S A 1997;94:1544–9.
- Noble F, Cox BM. Differential desensitization of mu- and delta-opioid receptors in selected neural pathways following chronic morphine treatment. Br J Pharmacol 1996;117:161–9.
- Ferguson SS, Barak LS, Zhang J, Caron MG. G-protein-coupled receptor regulation: role of G-protein-coupled receptor kinases and arrestins. Can J Physiol Pharmacol 1996;74:1095–110.
- Krupnick JG, Benovic JL. The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 1998;38:289–319.
- Zuo Z. The role of opioid receptor internalization and beta-arrestins in the development of opioid tolerance. Anesth Analg 2005;101:728–34, table of contents.
- Bohn LM, Lefkowitz RJ, Gainetdinov RR, Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 1999;286:2495–8.
- Bohn LM, Gainetdinov RR, Lin FT, Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence. Nature 2000;408:720–3.
- Janowski BA, Hu J, Corey DR. Silencing gene expression by targeting chromosomal DNA with antigene peptide nucleic acids and duplex RNAs. Nat Protoc 2006;1:436–43.
- Janowski BA, Corey DR. Inhibiting transcription of chromosomal DNA using antigene RNAs. Nucleic Acids Symp Ser (Oxf) 2005:367–8.
- Janowski BA, Huffman KE, Schwartz JC, Inhibiting gene expression at transcription start sites in chromosomal DNA with antigene RNAs. Nat Chem Biol 2005;1:216–22.
- Chu Y, Yue X, Younger ST, Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res 2010;38:7736–48.
- Naldini L, Blomer U, Gage FH, Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 1996;93:11382–8.
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109–10.
- Tian X, Wang G, Xu Y, An improved tet-on system for gene expression in neurons delivered by a single lentiviral vector. Hum Gene Ther 2009;20:113–23.
- Yang P, Arnold SA, Habas A, Ciliary neurotrophic factor mediates dopamine D2 receptor-induced CNS neurogenesis in adult mice. J Neurosci 2008;28:2231–41.
- Wang X, Tang R, Xue Z, Lentivector-mediated RNAi efficiently downregulates expression of murine TNF-alpha gene in vitro and in vivo. J Huazhong Univ Sci Technol Med Sci 2009;29:112–7.
- Wang GM, Tian XB, Chen JP, Prevention of neuropathic pain in an animal model of spare nerve injury following oral immunization with recombinant adenovirus serotype 5-mediated NR2B gene transfer. Gene Ther 2007;14:1681–7.
- Minville V, Fourcade O, Girolami JP, Tack I. Opioid-induced hyperalgesia in a mice model of orthopaedic pain: preventive effect of ketamine. Br J Anaesth 2010;104:231–8.
- Hecker JG, Hall LL, Irion VR. Nonviral gene delivery to the lateral ventricles in rat brain: initial evidence for widespread distribution and expression in the central nervous system. Mol Ther 2001;3:375–84.
- Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials. JAMA 2005;293:3043–52.
- Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev 2006;3:CD006146.
- Colson J, Koyyalagunta D, Falco FJ, Manchikanti L. A systematic review of observational studies on the effectiveness of opioid therapy for cancer pain. Pain Physician 2011;14:E85–102.
- Kieffer BL. Opioids: first lessons from knockout mice. Trends Pharmacol Sci 1999;20:19–26.
- Tan M, Walwyn WM, Evans CJ, Xie CW. p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons. J Biol Chem 2009;284:6270–81.
- Fan XL, Zhang JS, Zhang XQ, Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine. Neuroscience 2003;117:383–9.
- Hurle MA. Changes in the expression of G protein-coupled receptor kinases and beta-arrestin 2 in rat brain during opioid tolerance and supersensitivity. J Neurochem 2001;77:486–92.
- Hernandez L, Romero A, Almela P, Tolerance to the antinociceptive effects of peripherally administered opioids. Expression of beta-arrestins. Brain Res 2009;1248:31–9.
- Przewlocka B, Sieja A, Starowicz K, Knockdown of spinal opioid receptors by antisense targeting beta-arrestin reduces morphine tolerance and allodynia in rat. Neurosci Lett 2002;325:107–10.
- Li Y, Liu X, Liu C, Improvement of morphine-mediated analgesia by inhibition of beta-arrestin 2 expression in mice periaqueductal gray matter. Int J Mol Sci 2009;10:954–63.
- Jiang B, Shi Y, Li H, Decreased morphine analgesia in rat overexpressing beta-arrestin 2 at periaqueductal gray. Neurosci Lett 2006;400:150–3.
- Bohn LM, Lefkowitz RJ, Caron MG. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 2002;22:10494–500.
- Dang VC, Christie MJ. Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 2012;165:1704–16.
- Raehal KM, Walker JK, Bohn LM. Morphine side effects in beta-arrestin 2 knockout mice. J Pharmacol Exp Ther 2005;314:1195–201.